Cargando…
Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease
Drosophila melanogaster is a valuable model organism for a wide range of biological exploration. The well-known advantages of D. melanogaster include its relatively simple biology, the ease with which it is genetically modified, the relatively low financial and time costs associated with their short...
Autores principales: | Miller, Sean J., Darji, Rayyan Y., Walaieh, Sami, Lewis, Jhemerial A., Logan, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568035/ https://www.ncbi.nlm.nih.gov/pubmed/37840914 http://dx.doi.org/10.3389/fneur.2023.1271941 |
Ejemplares similares
-
Nutritional senolytics and senomorphics: Implications to immune cells metabolism and aging – from theory to practice
por: Luís, Carla, et al.
Publicado: (2022) -
Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics
por: Okuno, Keisuke, et al.
Publicado: (2020) -
Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
por: Miller, Sean J., et al.
Publicado: (2022) -
Could Hyaluronic Acid Be Considered as a Senomorphic Agent in Knee Osteoarthritis? A Systematic Review
por: Bernetti, Andrea, et al.
Publicado: (2023) -
Role of GDF15/MAPK14 Axis in Chondrocyte Senescence as a Novel Senomorphic Agent in Osteoarthritis
por: Weng, Pei-Wei, et al.
Publicado: (2022)